View All HCPCS Sections

• M1349

  Patients who did not have a net increase in pam score of at least 3 points within a 4 to 12 month period

• M1350

  Patients who had a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter

• M1351

  Patients who had a suicide safety plan initiated, reviewed, or updated and reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation

• M1352

  Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessment

• M1353

  Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter

• M1354

  Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation

• M1355

  Suicide risk based on their clinician's evaluation or a clinician-rated tool

• M1356

  Patients who died during the measurement period

• M1357

  Patients who had a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment

• M1358

  Patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment

• M1359

  Index assessment during the denominator period when the suicidal ideation and/or behavior symptoms or increased suicide risk by clinician determination occurs and a non-zero c-ssrs score is obtained

• M1360

  Suicidal ideation and/or behavior symptoms based on the c-ssrs

• M1361

  Suicide risk based on their clinician's evaluation or a clinician-rated tool

• M1362

  Patients who died during the measurement period

• M1363

  Patients who did not have a follow-up assessment within 120 days of the index assessment

• M1364

  Calculated 10-year ascvd risk score of >= 20 percent during the performance period

• M1365

  Patient encounter during the performance period with hospice and palliative care specialty code 17

• M1366

  Focusing on women's health mips value pathway

• M1367

  Quality care for the treatment of ear, nose, and throat disorders mips value pathway

• M1368

  Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway

• M1369

  Quality care in mental health and substance use disorders mips value pathway

• M1370

  Rehabilitative support for musculoskeletal care mips value pathway

• M1371

  Most recent glycemic status assessment (hba1c or gmi) level < 7.0%

• M1372

  Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%

• M1373

  Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0%

• M1374

  An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period

• M1375

  An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period

• M1376

  An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period

• M1377

  Recommended follow-up interval for repeat colonoscopy of 10 years documented in colonoscopy report and communicated with patient

• M1378

  Documentation of medical reason(s) for not recommending a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is >= 66 years old, or life expectancy < 10 years, other medical reasons)

• M1379

  A 10 year follow-up interval for colonoscopy not recommended, reason not otherwise specified

• M1380

  Filled at least two prescriptions during the performance period for any combination of the qualifying oral antipsychotic medications listed under "denominator note" or the long-acting injectable antipsychotic medications listed under "denominator note"

• M1381

  Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedure

• M1382

  Patient encounter during the performance period with place of service code 11

• M1383

  Acute pvd

• M1384

  Patients who died during the performance period

• M1385

  Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up

• M1386

  Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period

• M1387

  Patients who died during the performance period

• M1388

  Patients with documentation of an exam performed for recurrence of melanoma

• M1390

  Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period

• M1391

  All patients who were diagnosed with recurrent melanoma during the current performance period

• M1392

  Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)

• M1393

  Patients who were not diagnosed with recurrent melanoma during the current performance period

• M1394

  Stages i-iii breast cancer

• M1395

  Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group

• M1396

  Patients on a therapeutic clinical trial

• M1397

  Patients with recurrence/disease progression

• M1398

  Patients with baseline and follow-up promis surveys documented in the medical record

• M1399

  Patients who leave the practice during the follow-up period

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/3/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.